Anti-SL9B1/ SLC9B1/ NHA1 monoclonal antibody

Anti-SL9B1/ SLC9B1/ NHA1 antibody for FACS & in-vivo assay

Target products collectionGo to SLC9B1/SLC9B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1677-Ab-1/ GM-Tg-hg-MP1677-Ab-2Anti-Human SLC9B1 monoclonal antibodyHuman
GM-Tg-rg-MP1677-Ab-1/ GM-Tg-rg-MP1677-Ab-2Anti-Rat SLC9B1 monoclonal antibodyRat
GM-Tg-mg-MP1677-Ab-1/ GM-Tg-mg-MP1677-Ab-2Anti-Mouse SLC9B1 monoclonal antibodyMouse
GM-Tg-cynog-MP1677-Ab-1/ GM-Tg-cynog-MP1677-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC9B1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1677-Ab-1/ GM-Tg-felg-MP1677-Ab-2Anti-Feline SLC9B1 monoclonal antibodyFeline
GM-Tg-cang-MP1677-Ab-1/ GM-Tg-cang-MP1677-Ab-2Anti-Canine SLC9B1 monoclonal antibodyCanine
GM-Tg-bovg-MP1677-Ab-1/ GM-Tg-bovg-MP1677-Ab-2Anti-Bovine SLC9B1 monoclonal antibodyBovine
GM-Tg-equg-MP1677-Ab-1/ GM-Tg-equg-MP1677-Ab-2Anti-Equine SLC9B1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1677-Ab-1/ GM-Tg-hg-MP1677-Ab-2; GM-Tg-rg-MP1677-Ab-1/ GM-Tg-rg-MP1677-Ab-2;
GM-Tg-mg-MP1677-Ab-1/ GM-Tg-mg-MP1677-Ab-2; GM-Tg-cynog-MP1677-Ab-1/ GM-Tg-cynog-MP1677-Ab-2;
GM-Tg-felg-MP1677-Ab-1/ GM-Tg-felg-MP1677-Ab-2; GM-Tg-cang-MP1677-Ab-1/ GM-Tg-cang-MP1677-Ab-2;
GM-Tg-bovg-MP1677-Ab-1/ GM-Tg-bovg-MP1677-Ab-2; GM-Tg-equg-MP1677-Ab-1/ GM-Tg-equg-MP1677-Ab-2
Products NameAnti-SLC9B1 monoclonal antibody
Formatmab
Target NameSLC9B1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC9B1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SL9B1/ SLC9B1/ NHA1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1677
    Target NameSLC9B1
    Gene ID150159,74446,365946,710949,100855458,101085373,100068093
    Gene Symbol and Synonyms1700094G20Rik,4933424B12Rik,4933425K02Rik,mtsNHE,NHA1,NHEDC1,Nhedc2,RGD1305087,SLC9B1
    Uniprot AccessionQ4ZJI4
    Uniprot Entry NameSL9B1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164037
    Target ClassificationN/A

    The target: SLC9B1, gene name: SLC9B1, also named as NHA1, NHEDC1. The protein encoded by this gene is a sodium/hydrogen exchanger and transmembrane protein. Highly conserved orthologs of this gene have been found in other mammalian species. The expression of this gene may be limited to testis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.